Medical Animation Dermatology Animation

Cancer Institute Of New Jersey Receives Nearly $768,000 To Investigate A New Therapeutic Path Against Melanoma
With 2,300 New Jersey residents diagnosed with melanoma this year, the Garden State ranks sixth in the nation in new cases of the disease, according to the American Cancer Society. It is that statistic on which a scientist at The Cancer Institute of New Jersey (CINJ) hopes to have impact, thanks to a $768,000 grant awarded by the American Cancer Society to study melanoma development. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

LATISSEâ„¢- New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes
Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSEâ„¢ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSEâ„¢ is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

Arpida Publishes Top-Line Data Of Phase II "Intravenous-To-Oral" Switch Trial With Oral Iclaprim
Arpida Ltd. (SWX: ARPN) announces positive top-line data of the Phase II 'intravenous-to-oral' switch trial with oral iclaprim in patients with complicated Skin and Skin Structure Infections (cSSSI). The top-line results demonstrated high clinical cure rates of over 90% following the step-down therapy with oral iclaprim administered after two days of initial treatment with intravenous vancomycin.

Chorionic Villus Sampling May Increase Risk Of Hemangiomas
Performing chorionic villus sampling (CVS) for prenatal diagnosis may lead to an increased rate of blood vessel malformations called hemangiomas in infants, according to a review in the November Journal of Craniofacial Surgery.

Which? Bid To Stop Online Botox Promotions
eBay has agreed to remove illegal Botox adverts* from its popular site after Which? discovered over 240 instances of unlawful advertising of the product in just five days**. Sixteen companies and individuals were found advertising the prescription only medicine to the public, with many unaware they were breaking the law***.

Dangerous Skin Cancer
The German Cancer Society has worked out new guidelines for the diagnosis and treatment of malignant melanoma a disease with unfavorable prognosis. Malignant melanoma is responsible for 90% of deaths from skin cancer. The incidence has increased 5-fold within the last 30 years and UV radiation is thought to be an important cause. Caucasian populations are most affected.

Basilea Pharmaceutica Opens U.S. Phase III Study On Alitretinoin For The Treatment Of Severe Chronic Hand Eczema
Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that it has opened a clinical phase III study on alitretinoin in the U.S. The "HANDEL" trial (HAND Eczema research of aLitretinoin) is the first ever multi-centered, controlled clinical study for patients with severe chronic hand eczema (CHE) performed in the U.S. "There is a real sense of excitement within the dermatology community with the start of this important trial," said Dr.

EpiDerm's Skin Irritation Test Fully Validated In European Union
MatTek Corporation announced that the ECVAM Scientific Advisory Committee (ESAC) endorsed the scientific validity of the Modified EpiDerm Skin Irritation Test (SIT) at its November meeting. ESAC concluded that the Modified EpiDerm SIT has sufficient accuracy and reliability for the prediction of skin irritating and non-irritating test substances. The Updated EpiDerm SIT is a modification of the previously validated EpiDerm skin irritation method (ESAC Statement, April 2007).

Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant
A multi-disciplinary team of doctors and surgeons at Cleveland Clinic recently performed the first near-total face transplant in the United States. In a 22-hour procedure performed within the past two weeks, surgeons transplanted 80 percent of a woman's face who suffered severe facial trauma -- essentially replacing her entire face, except for her upper eyelids, forehead, lower lip and chin.

Gene Function 'Lost' In Melanoma And Glioblastoma
Researchers at Georgetown University Medical Center have found a gene they say is inactivated in two aggressive cancers - malignant melanoma, a form of skin cancer, and glioblastoma multiforme, a lethal brain tumor. They add that because this gene, known as PTPRD, has recently been found to be inactivated in several other cancers as well, their discovery suggests that PTPRD may play a tumor suppressor role in a wide variety of different cancers.

Psoriasis Patients Have Higher Levels Of Obesity Hormone Leptin
The skin disease psoriasis has been associated with higher levels of the protein leptin, according to an article released on December 15, 2008 in Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis is a chronic autoimmune disease whose primary symptom is the presence of a persistent red, scaly rash.

American Academy Of Dermatology Issues Statement On FDA Report To Congress About Labeling Information On Indoor Tanning Devices
The American Academy of Dermatology (Academy) issued a statement in response to the Food and Drug Administration's Report to Congress about labeling information on the relationship between the use of indoor tanning devices and development of skin cancer or other skin damage. The FDA report was submitted pursuant to Section 230 of the Food and Drug Administration Amendments Act of 2007.

Synvista Therapeutics Announces First Dosing Of SYI-2074 In Clinical Trial For Psoriasis
Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has dosed the first patient in a 30-patient Phase 2 clinical trial of its proprietary topical GPx-mimetic, SYI-2074, in patients with psoriasis. The trial is planned to be a 28-day multi-center, randomized, double-blind, placebo controlled study to assess the efficacy of topical SYI-2074, applied twice daily, for the treatment of chronic, mild-to-moderate plaque psoriasis in adults. The trial is being conducted in three centers in Israel.

Higher Levels Of Obesity-Related Hormone Found In Patients With Psoriasis
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than persons without psoriasis, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis is an autoimmune disease that results in a red, scaly rash.

Biocompatibles International Plc Filing For CE Mark Approval For Dermal Filler Bead
Biocompatibles (LSE:BII) is pleased to announce the filing for CE Mark approval by the Company's development and marketing partner Merz Pharmaceuticals GmbH for the Cosmetic Dermal Filler Bead. The product has been licensed to Merz and will be manufactured by Biocompatibles' German subsidiary, CellMed AG. The global market for aesthetic dermal filler products1 is at least $760m2. The current market consists mainly of products manufactured from collagen and hyaluronic acid.